EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis

Daniele Tienforti, Gennaro Puocci, Claudia Venditti, Valentina Gizzi, Carlo Pisanò, Elisa Cocci, Elisabetta Perfetto, Francesco D'Alessandro, Luca Spagnolo, Marco Giorgio Baroni, Arcangelo Barbonetti

Clinical Endocrinology · 2026-08 · 105 (2) · 237-244

DOI: 10.1111/cen.70140 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Objective To evaluate the effect of inositol supplementation on biochemical hyperandrogenism in women with polycystic ovary syndrome (PCOS) and to explore whether metabolic phenotype modifies the endocrine response. Design Systematic review and meta‐analysis of randomized controlled trials conducted in accordance with PRISMA guidelines. Patients Women diagnosed with PCOS according to established criteria (NIH, Rotterdam, or AE‐PCOS). Nine eligible trials comprising a total of 440 participants were included. Measurements Primary outcomes were serum total testosterone (TT), calculated free testosterone (cFT), free androgen index (FAI), and sex hormone–binding globulin (SHBG). Prespecified subgroup analyses explored differences according to body mass index (BMI) and insulin resistance (HOMA‐IR). Results Inositol supplementation was associated with significant reductions in TT (SMD –1.30; 95% CI –2.17 to –0.42), cFT, and FAI, together with an increase in SHBG. Substantial heterogeneity was observed for several outcomes. In subgroup analyses, the largest and most consistent reduction in TT was observed among normal‐weight women (BMI < 25 kg/m²) (SMD –2.97; 95% CI –3.78 to –2.16), with minimal heterogeneity ( I ² = 9%). No significant improvements were detected in overweight or obese women, nor in women with insulin resistance when considered independently of BMI. These subgroup findings should be interpreted as exploratory. Conclusions Inositol supplementation is associated with improvements in biochemical hyperandrogenism in women with PCOS, with evidence of phenotype‐dependent variability. The most consistent biochemical response was observed in normal‐weight individuals. These findings support a metabolically informed, hypothesis‐generating framework and highlight the need for adequately powered, phenotype‐stratified trials incorporating clinically meaningful outcomes, including standardized measures of hirsutism, ovulatory function, and patient‐reported endpoints.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →